WASHINGTON - Researchers have discovered that an active compound called Polyphenon E found in green tea can slow the progression of prostate cancer.
The study examined 26 men between the ages of 41 to 72 years, diagnosed with prostate cancer. They were all given four capsules containing Polyphenon E.
Results suggested a significant reduction in serum markers predictive of prostate cancer progression.
Similarly, results of a recent year-long clinical trial conducted in Italy revealed that consumption of green tea polyphenols reduced the risk of developing prostate cancer in men with high grade prostate intraepithelial neoplasia (HGPIN).
James A. Cardelli, director of basic and translational research at the Feist-Weiller Cancer Centre in Louisiana said that ” These studies are just the beginning and a lot of work remains to be done, however, we think that the use of tea polyphenols alone or in combination with other compounds currently used for cancer therapy should be explored as an approach to prevent cancer progression and recurrence.”
These findings were published in Cancer Prevention Research, a journal of the American Association for Cancer Research.